BrightPath Biotherapeutics Co., Ltd. Stock: price and insider trades · Japan
ブライトパス・バイオ株式会社
No insider purchase over the last 90 days. The latest, by Unknown, was filed 25 Jul 2022.
BrightPath Biotherapeutics Co., Ltd.: what insiders have been doing
Every trade that managers of BrightPath Biotherapeutics Co., Ltd. disclose to EDINET (Japan FSA) is tracked on this page. The company sits in the Health Care sector. The past year has been quiet: not a single insider filing for BrightPath Biotherapeutics Co., Ltd. The previous disclosure was published on 11 July 2025.
Our records for BrightPath Biotherapeutics Co., Ltd. go back to 2022, with 5 purchases and 172 sales on the open market in total.
These figures are compiled from regulatory filings published by EDINET (Japan FSA). They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 0.3% of flowShareXTKSEDINET:S100WCFV
- 0.5% of flowShareXTKSEDINET:S100WBWL
- 0.8% of flowShareXTKSEDINET:S100W7IQ
- 1.3% of flowShareXTKSEDINET:S100W3BW
- 2.0% of flowShareXTKSEDINET:S100VTHP
- 1.6% of flowShareXTKSEDINET:S100VT5B
- 1.6% of flowShareXTKSEDINET:S100VPJZ
- 10.2% of flowShareXTKSEDINET:S100VMT9
- 1.9% of flowShareXTKSEDINET:S100VIZA
- 25.1% of flowShareXTKSEDINET:S100VB43
- 7.9% of flowShareXTKSEDINET:S100UTVP
- 2.6% of flowShareXTKSEDINET:S100UKS0
- 23.0% of flowShareXTKSEDINET:S100U9TY
- 11.5% of flowShareXTKSEDINET:S100U7QN
- ShareXTKSEDINET:S100U3ZE
- 3.0% of flowShareXTKSEDINET:S100U3IF
- 3.3% of flowShareXTKSEDINET:S100U1ZX
- 1.0% of flowShareXTKSEDINET:S100U13R
- 3.4% of flowShareXTKSEDINET:S100U170
- 2.6% of flowShareXTKSEDINET:S100T74Z
- 57,900 sharesShareXTKSEDINET:S100T74Z:T1
- 82,900 sharesShareXTKSEDINET:S100T74Z:T2
- 109,100 sharesShareXTKSEDINET:S100T74Z:T5
- 64,000 sharesShareXTKSEDINET:S100T74Z:T8
- 96,700 sharesShareXTKSEDINET:S100T74Z:T11
25 of 222 declarations
About BrightPath Biotherapeutics Co., Ltd.
BrightPath Biotherapeutics is a company focused on the health and pharmaceutical sector, dedicated to developing innovative therapies. It is listed on the XTKS market.
